Share of new orphan drugs available in Europe in 2023, by country

Percentage of orphan drugs approved by the EMA available to patients in Europe as of 2023, by country

Loading statistic...
Download
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Use Ask Statista Research Service

Release date

April 2023

Region

Europe

Survey time period

as of January 5, 2023

Supplementary notes

61 orphan drug products were approved by the European Medicines Agency between 2018 and 2021.
In most countries availability equates to granting of access to the reimbursement list, except in DK, FI, LU, NO, SE some hospital products are not covered by the general reimbursement scheme.
* Country did not complete a full dataset and therefore availability may be unrepresentative.
** In Spain, the WAIT analysis does not identify those medicinal products being accessible earlier in conformity with Spain's Royal Decree 1015/2009 relating to Medicines in Special Situations.

Citation formats
Statista Accounts: Access All Statistics. Starting from $2,148 USD / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Starter Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$199 USD $179 USD / Month *
in the first 12 months
Professional Account
Full access

Business Solutions including all features.

* Prices do not include sales tax.

Statistics on " Orphan drugs "

Other statistics that may interest you Orphan drugs

Rare diseases

4

Market overview

5

Companies

4

Products

6

Research and development

6

Further related statistics

17
Statista Accounts: Access All Statistics. Starting from $2,148 USD / Year
Learn more about how Statista can support your business.